Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Nipple-Sparing Mastectomy is Not Associated with a Delay of Adjuvant Treatment.

Albright EL, Schroeder MC, Foster K, Sugg SL, Erdahl LM, Weigel RJ, Lizarraga IM.

Ann Surg Oncol. 2018 Apr 18. doi: 10.1245/s10434-018-6446-1. [Epub ahead of print]

PMID:
29671138
2.

Invited commentary on "outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer patients" by Murphy et al.

Scott-Conner CE, Sugg SL, Lizarraga I.

Am J Surg. 2017 Apr;213(4):814-815. doi: 10.1016/j.amjsurg.2016.09.028. Epub 2016 Oct 20. No abstract available.

PMID:
28029375
3.

Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease.

Wu VT, Lorenzen AW, Beck AC, Reid VJ, Sugg SL, Howe JR, Pollard JH, Lal G, Weigel RJ.

Surgery. 2017 Jan;161(1):147-155. doi: 10.1016/j.surg.2016.06.066. Epub 2016 Nov 15.

4.

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer.

Spanheimer PM, Lorenzen AW, De Andrade JP, Kulak MV, Carr JC, Woodfield GW, Sugg SL, Weigel RJ.

Ann Surg Oncol. 2015 Dec;22(13):4287-94. doi: 10.1245/s10434-015-4597-x. Epub 2015 May 14.

5.

The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.

Park JM, Wu T, Cyr AR, Woodfield GW, De Andrade JP, Spanheimer PM, Li T, Sugg SL, Lal G, Domann FE, Zhang W, Weigel RJ.

Oncogene. 2015 Dec 10;34(50):6105-14. doi: 10.1038/onc.2015.59. Epub 2015 Mar 16.

6.

Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.

Xia C, Schroeder MC, Weigel RJ, Sugg SL, Thomas A.

Ann Surg Oncol. 2014 Dec;21(13):4133-8. doi: 10.1245/s10434-014-3852-x. Epub 2014 Jun 17.

7.

Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.

Spanheimer PM, Park JM, Askeland RW, Kulak MV, Woodfield GW, De Andrade JP, Cyr AR, Sugg SL, Thomas A, Weigel RJ.

Clin Cancer Res. 2014 Apr 15;20(8):2115-25. doi: 10.1158/1078-0432.CCR-13-2221. Epub 2014 Feb 13.

8.

TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.

Cyr AR, Kulak MV, Park JM, Bogachek MV, Spanheimer PM, Woodfield GW, White-Baer LS, O'Malley YQ, Sugg SL, Olivier AK, Zhang W, Domann FE, Weigel RJ.

Oncogene. 2015 Jan 22;34(4):436-44. doi: 10.1038/onc.2013.569. Epub 2014 Jan 27.

9.

Preoperative evaluation of thyroglossal duct cysts: children versus adults--is there a difference?

Bhama AR, Smith RJ, Robinson RA, Weigel RJ, Sugg SL, Howe JR, Lal G.

Am J Surg. 2014 Jun;207(6):902-6. doi: 10.1016/j.amjsurg.2013.06.018. Epub 2013 Oct 26.

PMID:
24246260
10.

Review of risk factors for the development of contralateral breast cancer.

Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE.

Am J Surg. 2013 Nov;206(5):704-8. doi: 10.1016/j.amjsurg.2013.08.002. Epub 2013 Sep 6. Review.

PMID:
24016706
11.

Do giant parathyroid adenomas represent a distinct clinical entity?

Spanheimer PM, Stoltze AJ, Howe JR, Sugg SL, Lal G, Weigel RJ.

Surgery. 2013 Oct;154(4):714-8; discussion 718-9. doi: 10.1016/j.surg.2013.05.013. Epub 2013 Aug 23.

12.

Management of contralateral axillary sentinel lymph nodes detected on lymphoscintigraphy for breast cancer.

Lizarraga IM, Scott-Conner CE, Muzahir S, Weigel RJ, Graham MM, Sugg SL.

Ann Surg Oncol. 2013 Oct;20(10):3317-22. doi: 10.1245/s10434-013-3151-y. Epub 2013 Aug 22.

PMID:
23975295
13.

Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines.

Carr JC, Spanheimer PM, Rajput M, Dahdaleh FS, Lal G, Weigel RJ, Sugg SL, Liao J, Howe JR.

Ann Surg Oncol. 2013 Nov;20(12):3855-61. doi: 10.1245/s10434-013-3142-z. Epub 2013 Jul 25.

14.

Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

Maity B, Stewart A, O'Malley Y, Askeland RW, Sugg SL, Fisher RA.

Carcinogenesis. 2013 Aug;34(8):1747-55. doi: 10.1093/carcin/bgt128. Epub 2013 Apr 18.

15.

MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.

Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, Qian W, O'Malley YQ, Askeland RW, Sugg SL, Qian J, Lin J, Jiang Z, Yee AJ, Sefton M, Deng Z, Shan SW, Wang CH, Yang BB.

J Cell Sci. 2013 Mar 15;126(Pt 6):1440-53. doi: 10.1242/jcs.118299. Epub 2013 Feb 15.

16.

The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer.

Spanheimer PM, Carr JC, Thomas A, Sugg SL, Scott-Conner CE, Liao J, Weigel RJ.

Am J Surg. 2013 Jul;206(1):2-7. doi: 10.1016/j.amjsurg.2012.10.025. Epub 2013 Jan 31.

17.

Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt.

O'Malley Y, Lal G, Howe JR, Weigel RJ, Komorowski RA, Shilyansky J, Sugg SL.

Surgery. 2012 Dec;152(6):1218-24. doi: 10.1016/j.surg.2012.08.041.

PMID:
23158188
18.

MiR-93 enhances angiogenesis and metastasis by targeting LATS2.

Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, Mehta T, Deng Z, Yang BB.

Cell Cycle. 2012 Dec 1;11(23):4352-65. doi: 10.4161/cc.22670. Epub 2012 Oct 30.

19.

Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo.

Yan X, Doffek K, Yin C, Krein M, Phillips M, Sugg SL, Johnson B, Shilyansky J.

Cancer Immunol Immunother. 2012 Nov;61(11):1917-27. doi: 10.1007/s00262-012-1250-4. Epub 2012 Apr 5.

PMID:
22476407
20.

Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.

Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF.

Ann Surg Oncol. 2012 Jun;19(6):1887-96. doi: 10.1245/s10434-011-2193-2. Epub 2012 Jan 7.

21.

Sampling of secondary margins decreases the need for re-excision after partial mastectomy.

Guidroz JA, Larrieux G, Liao J, Sugg SL, Scott-Conner CE, Weigel RJ.

Surgery. 2011 Oct;150(4):802-9. doi: 10.1016/j.surg.2011.07.064.

PMID:
22000194
22.

Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.

Cheng G, Lopez M, Zielonka J, Hauser AD, Joseph J, McAllister D, Rowe JJ, Sugg SL, Williams CL, Kalyanaraman B.

Cancer Biol Ther. 2011 Oct 15;12(8):707-17. doi: 10.4161/cbt.12.8.16441. Epub 2011 Oct 15.

23.

Phosphatidylserine inhibits NFκB and p38 MAPK activation in human monocyte derived dendritic cells.

Doffek K, Chen X, Sugg SL, Shilyansky J.

Mol Immunol. 2011 Sep;48(15-16):1771-7. doi: 10.1016/j.molimm.2011.04.021. Epub 2011 May 31.

PMID:
21628073
24.

Surveillance and intervention after thyroid lobectomy.

Spanheimer PM, Sugg SL, Lal G, Howe JR, Weigel RJ.

Ann Surg Oncol. 2011 Jun;18(6):1729-33. doi: 10.1245/s10434-010-1544-8. Epub 2011 Jan 19.

PMID:
21246403
25.

PET-CT scans in recurrent or persistent differentiated thyroid cancer: is there added utility beyond conventional imaging?

Lal G, Fairchild T, Howe JR, Weigel RJ, Sugg SL, Menda Y.

Surgery. 2010 Dec;148(6):1082-9; discussion 1089-90. doi: 10.1016/j.surg.2010.09.015. Review.

PMID:
21134537
26.

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study.

Fisher CS, Cole DJ, Mitas M, Garrett-Meyer E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Baker MK.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:312-20. doi: 10.1245/s10434-010-1258-y. Epub 2010 Sep 19.

PMID:
20853052
27.

Identification of novel carcinogen-mediated mammary tumor susceptibility loci in the rat using the chromosome substitution technique.

Adamovic T, McAllister D, Wang T, Adamovic D, Rowe JJ, Moreno C, Lazar J, Jacob HJ, Sugg SL.

Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45. doi: 10.1002/gcc.20812.

28.

Risk factors for development and recurrence of primary breast abscesses.

Gollapalli V, Liao J, Dudakovic A, Sugg SL, Scott-Conner CE, Weigel RJ.

J Am Coll Surg. 2010 Jul;211(1):41-8. doi: 10.1016/j.jamcollsurg.2010.04.007.

PMID:
20610247
29.

Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism.

Fang SH, Guidroz JA, O'Malley Y, Lal G, Sugg SL, Howe JR, Jensen CS, Weigel RJ.

Ann Surg. 2010 Jan;251(1):107-13. doi: 10.1097/SLA.0b013e3181b5da28.

PMID:
20009751
30.

Determinants of survival in patients with calciphylaxis: a multivariate analysis.

Lal G, Nowell AG, Liao J, Sugg SL, Weigel RJ, Howe JR.

Surgery. 2009 Dec;146(6):1028-34. doi: 10.1016/j.surg.2009.09.022.

PMID:
19958929
31.

Electronic signature, attestation, and authorship (updated).

Barron D, Blumenthal L, Bourque S, Brovarny N, Childress J, Clark JS, Criswell DL, Dillard J, Dougherty M, Gardenier M, Gryzbowski D, Hall T, Hardison M, Hecht J, Hjort B, Jackson K, Johnson M, Lerch DM, Maxim DW, Mozie DI, Osi I, Panzarella D, Pavlick JL, Qazen U, Ray S, Spurrell L, Stephens D, Sugg S, Vernon K, Waugh TE, Wiedemann LA.

J AHIMA. 2009 Nov-Dec;80(11):62-9. No abstract available.

PMID:
19953798
32.

A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients.

Johnson MT, Guidroz JA, Smith BJ, Graham MM, Scott-Conner CE, Sugg SL, Weigel RJ.

Surgery. 2009 Oct;146(4):671-6; discussion 676-7. doi: 10.1016/j.surg.2009.06.025.

PMID:
19789026
33.

Microalterations of inherently unstable genomic regions in rat mammary carcinomas as revealed by long oligonucleotide array-based comparative genomic hybridization.

Adamovic T, McAllister D, Guryev V, Wang X, Andrae JW, Cuppen E, Jacob HJ, Sugg SL.

Cancer Res. 2009 Jun 15;69(12):5159-67. doi: 10.1158/0008-5472.CAN-08-4038. Epub 2009 Jun 9.

34.

When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?

Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, Howe JR.

Ann Surg Oncol. 2009 Aug;16(8):2237-44. doi: 10.1245/s10434-009-0524-3. Epub 2009 May 27.

PMID:
19472011
35.

Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy.

Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CE, Weigel RJ.

Ann Surg Oncol. 2009 May;16(5):1143-7. doi: 10.1245/s10434-009-0390-z. Epub 2009 Mar 7.

PMID:
19267158
36.

The influence of surgery in MEN-1 syndrome: observations over 150 years.

Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL, Pappas SG.

Surgery. 2008 Oct;144(4):695-701; discussion 701-2. doi: 10.1016/j.surg.2008.06.015.

PMID:
18847656
37.

Genetic mapping of mammary tumor traits to rat chromosome 10 using a novel panel of consomic rats.

Adamovic T, McAllister D, Rowe JJ, Wang T, Jacob HJ, Sugg SL.

Cancer Genet Cytogenet. 2008 Oct;186(1):41-8. doi: 10.1016/j.cancergencyto.2008.05.014.

PMID:
18786441
38.

An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo.

Sinkevicius KW, Burdette JE, Woloszyn K, Hewitt SC, Hamilton K, Sugg SL, Temple KA, Wondisford FE, Korach KS, Woodruff TK, Greene GL.

Endocrinology. 2008 Jun;149(6):2970-9. doi: 10.1210/en.2007-1526. Epub 2008 Mar 13.

39.

Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.

Shilyansky J, Jacobs P, Doffek K, Sugg SL.

J Pediatr Surg. 2007 Jan;42(1):54-61; discussion 61.

PMID:
17208541
40.

The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism.

Yen TW, Wilson SD, Krzywda EA, Sugg SL.

Surgery. 2006 Oct;140(4):665-72; discussion 672-4. Epub 2006 Sep 6.

PMID:
17011915
41.

CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells.

Lodge A, Yu P, Nicholl MB, Brown IE, Jackson CC, Schreiber K, Sugg SL, Schreiber H, Shilyansky J.

Cancer Immunol Immunother. 2006 Dec;55(12):1542-52. Epub 2006 Feb 21.

PMID:
16491399
42.

Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy.

Sugg SL, Krzywda EA, Demeure MJ, Wilson SD.

Surgery. 2004 Dec;136(6):1303-9.

PMID:
15657591
43.

Phosphatidylserine regulates the maturation of human dendritic cells.

Chen X, Doffek K, Sugg SL, Shilyansky J.

J Immunol. 2004 Sep 1;173(5):2985-94.

44.

Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells.

Nicholl M, Lodge A, Brown I, Sugg SL, Shilyansky J.

J Pediatr Surg. 2004 Jun;39(6):941-6; discussion 941-6. Erratum in: J Pediatr Surg. 2004 Dec;39(12):1890. Shilyansky, Joel [added].

PMID:
15185230
45.

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.

Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Metcalf JS, Elliott BM, Brothers T, Robison J, Mitas M, Cole DJ.

Ann Surg. 2004 Jun;239(6):828-37; discussion 837-40.

46.

Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells.

Chen X, Doffek K, Sugg SL, Shilyansky J.

J Pediatr Surg. 2003 Jun;38(6):901-5.

PMID:
12778389
47.

Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism.

Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL.

Arch Surg. 2002 Jun;137(6):659-68; discussion 668-9.

PMID:
12049536
48.

Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma.

Witteles RM, Straus II FH, Sugg SL, Koka MR, Costa EA, Kaplan EL.

Arch Surg. 2001 Jun;136(6):656-63. Review.

PMID:
11387003
49.

Should internal mammary nodes be sampled in the sentinel lymph node era?

Sugg SL, Ferguson DJ, Posner MC, Heimann R.

Ann Surg Oncol. 2000 Apr;7(3):188-92.

PMID:
10791848
50.

Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia.

Sugg SL, Ezzat S, Zheng L, Rosen IB, Freeman JL, Asa SL.

Clin Endocrinol (Oxf). 1998 Nov;49(5):629-37.

PMID:
10197079

Supplemental Content

Support Center